RecruitingNot ApplicableNCT05753774

Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders

Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Functional Gastrointestinal Disorders in Children


Sponsor

Biao Zou

Enrollment

100 participants

Start Date

Aug 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Safety and efficacy of FMT in Pediatric Functional Gastrointestinal Disorders


Eligibility

Min Age: 1 YearMax Age: 15 Years

Inclusion Criteria1

  • The diagnosis and classification of patients with FGIDs were in accordance with the ROME IV criteria for children

Exclusion Criteria3

  • organic gastrointestinal disease (as established by medical history, blood routine, biochemistry, c-reaction protein, erythrocyte sedimentation rate, and fecal routine examinations.)
  • other chronic disease
  • growth failure

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALFMT

FMT is a technique in which intestinal microbiota are transferred from a healthy screened donor to a patient, with the goal being to introduce or restore a stable microbial community in the gut. FMT was given 1-3courses, 3-6 times per courses

DRUGConventional drugs

Conventional drugs include probiotics and omeprazole, and cyproheptadine and moxapride


Locations(1)

Tongji Hospital

Wuhan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05753774


Related Trials